Atlas Trials

A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE)

Clinical trial NCT00943111 · COMPLETED

Trial details

NCT number
NCT00943111
Sponsor
Genzyme, a Sanofi Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Gaucher Disease, Type 1
Start date
2009-09-01
Primary completion
2012-11-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.